查詢結果分析
來源資料
相關文獻
- Hemorrhagic Hepatocellular Adenoma Occurring in a Patient with Hyperaldosteronism
- Adrenal Adenoma Removal Improves Glucose Control in a Diabetic Patient with Primary Aldosteronism: A Case Report and Literature Review
- 腎上腺皮質腺瘤
- 腎水泡擬似腎上腺皮質腺瘤
- Primary Aldosteronism: 13 Cases Analysis
- 肝細胞腺瘤
- Liver Cell Adenoma with Concomitant Hepatocellular Carcinoma: Report of Two Cases
- 多發性肝細胞腺瘤
- 高醛固酮症
- 高醛固酮症
頁籤選單縮合
題 名 | Hemorrhagic Hepatocellular Adenoma Occurring in a Patient with Hyperaldosteronism=一位高醛固酮症患者發生出血性肝細胞腺瘤 |
---|---|
作 者 | 林煒晟; 王蒼恩; 王朝弘; 楊博勝; 王鴻源; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 30:1 2014.03[民103.03] |
頁 次 | 頁65-69 |
分類號 | 415.934 |
關鍵詞 | 肝細胞腺瘤; 高醛固酮; 腎上腺皮質腺瘤; Hepatocellular adenoma; Hyperaldosteronism; Adrenal cortical adenoma; Spironolactone; |
語 文 | 英文(English) |
中文摘要 | 肝細胞腺瘤是一種罕見、良性且來源不明的腫瘤。它主要發生在長期服用避孕藥的 年輕成年女性。Spironolactone 是廣泛使用的利尿劑。儘管 spironolactone 經常使用,極少 有肝細胞毒性的報導。至目前為止,沒有英文文獻在關於高醛固酮症患者伴有肝細胞腺 瘤使用 spironolactone 的報告。在此,我們提出了一個長期 spironolactone 治療下的高醛固 酮症患者伴有肝細胞腺瘤。 肝細胞腺瘤發生擴大和出血性變化。所以在治療這類患者, eplerenone 或手術介入可能優於 spironolactone。 |
英文摘要 | Hepatocellular adenoma (HCA) is a rare, benign neoplasm of uncertain origin. It occurs predominantly in young adult women using long-term oral contraceptives. Spironolactone is a widely used diuretic agent. Despite the frequent use of spironolactone, there have been very few cases of hepatocellular toxicity reported. Furthermore, there are no reports to date in the English literature about HCA associated with spironolactone treatment for hyperaldosteronism. Herein, we present a HCA patient with hyperaldosteronism, who received spironolactone treatment for an extended period of time. The patient’s HCA was enlarged and underwent hemorrhagic change. Therefore, eplerenone or surgical intervention may be superior to spironolactone in this patient. |
本系統中英文摘要資訊取自各篇刊載內容。